Professor of the Public Understanding of Risk
Research Interests: Public understanding of uncertainty and risk, Bayesian methods, biostatistics, performance assessment
Examples sheets and lecture notes can be found on my teaching page.
Publications
How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation?
– Value Health
(2011)
14,
371
(doi: 10.1016/j.jval.2010.09.001)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
– Health technology assessment (Winchester, England)
(2011)
15,
1
(doi: 10.3310/hta15100)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
– Health technology assessment (Winchester, England)
(2011)
15,
Quantifying uncertainty
(2011)
17
Barriers to Health Information and Building Solutions
– BETTER DOCTORS, BETTER PATIENTS, BETTER DECISIONS: ENVISIONING HEALTH CARE 2020
(2011)
191
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: A systematic review and economic evaluation
– Health Technology Assessment
(2011)
15,
134
(doi: 10.3310/hta15100)
Modelling Bias in Combining Small Area Prevalence Estimates from Multiple Surveys
– Journal of the Royal Statistical Society. Series A, (Statistics in Society)
(2010)
174,
31
Mathematics and medical statistics
(2010)
921
Designing and implementing sample and data collection for an international genetics study: The Type 1 Diabetes Genetics Consortium (T1DGC)
– Clinical Trials
(2010)
7,
S5
(doi: 10.1177/1740774509356002)
- <
- 14 of 44